About me
Dr. Liang Zhao is currently a professor and establishing the Center for Global Regulatory Science and Innovation at the School of Pharmacy, University of California San Francisco (UCSF). Prior to joining UCSF, he had served as the Director of Division of Quantitative Methods and Modeling (DQMM), ORS/OGD/CDER/FDA between 2015 and 2024. He has demonstrated excellence and leadership in drug development and regulatory science for new and generic drugs during his 20-year professional tenure including in Pharsight (acquired by Certara) as an associate consultant, BMS as a research investigator, MedImmune (now AstraZeneca) as an Associate Director, and FDA as Clinical Pharmacology reviewer, Pharmacometrics Team Leader for new drug development.
